166 related articles for article (PubMed ID: 28954118)
61. Human T-cell lymphotropic virus-I in Latin America.
Gotuzzo E; Arango C; de Queiroz-Campos A; Istúriz RE
Infect Dis Clin North Am; 2000 Mar; 14(1):211-39, x-xi. PubMed ID: 10738680
[TBL] [Abstract][Full Text] [Related]
62. Adult T-cell lymphoma with HTLV-I and HTLV-II infection.
Venkitaraman R; Sagar TG; George MK
South Med J; 2007 Nov; 100(11):1178-9. PubMed ID: 17984755
[No Abstract] [Full Text] [Related]
63. Global epidemiology of HTLV-I infection and associated diseases.
Proietti FA; Carneiro-Proietti AB; Catalan-Soares BC; Murphy EL
Oncogene; 2005 Sep; 24(39):6058-68. PubMed ID: 16155612
[TBL] [Abstract][Full Text] [Related]
64. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
[TBL] [Abstract][Full Text] [Related]
65. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Brazil.
Araújo Ade Q; de Andrada-Serpa MJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S33-7. PubMed ID: 8797701
[TBL] [Abstract][Full Text] [Related]
66. Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.
Martinez ARM; Casseb RF; Martins CR; Nucci A; França MC
J Neurovirol; 2018 Jun; 24(3):369-371. PubMed ID: 29318453
[TBL] [Abstract][Full Text] [Related]
67. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
68. HTLV-1 and associated adult T-cell leukemia/lymphoma.
Mahieux R; Gessain A
Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
[TBL] [Abstract][Full Text] [Related]
69. In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses.
Beilke MA; In DR; Gravell M; Hamilton RS; Mora CA; Leon-Monzon M; Rodgers-Johnson PE; Gajdusek DC; Gibbs CJ; Zaninovic V
J Med Virol; 1991 Jan; 33(1):64-71. PubMed ID: 1849984
[TBL] [Abstract][Full Text] [Related]
70. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects.
Touzé E; Gessain A; Lyon-Caen O; Gout O
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S38-45. PubMed ID: 8797702
[TBL] [Abstract][Full Text] [Related]
71. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
[TBL] [Abstract][Full Text] [Related]
72. HTLV-I infection and adult T-cell leukemia in Brazil: an overview.
de Oliveira Mdo S; Hamerschlak N; Chiattone C; Loureiro P
Sao Paulo Med J; 1996; 114(3):1177-85. PubMed ID: 9181750
[TBL] [Abstract][Full Text] [Related]
73. Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children.
La Grenade L; Manns A; Fletcher V; Derm D; Carberry C; Hanchard B; Maloney EM; Cranston B; Williams NP; Wilks R; Kang EC; Blattner WA
Arch Dermatol; 1998 Apr; 134(4):439-44. PubMed ID: 9554295
[TBL] [Abstract][Full Text] [Related]
74. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saeidi M; Sasannejad P; Foroughipour M; Shahami S; Shoeibi A
Acta Neurol Belg; 2011 Mar; 111(1):41-4. PubMed ID: 21510232
[TBL] [Abstract][Full Text] [Related]
75. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.
Saito M; Eiraku N; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2005 May; 232(1-2):29-35. PubMed ID: 15850579
[TBL] [Abstract][Full Text] [Related]
76. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
77. Inflammatory manifestations of HTLV-1 and their therapeutic options.
Martin F; Taylor GP; Jacobson S
Expert Rev Clin Immunol; 2014 Nov; 10(11):1531-46. PubMed ID: 25340428
[TBL] [Abstract][Full Text] [Related]
78. Human T-cell leukaemia/lymphoma virus type 1-associated infective dermatitis in Africa: a report of five cases from Senegal.
Mahé A; Meertens L; Ly F; Sow PS; Diop CT; Samb ND; Diop OM; Valensi F; Gessain A
Br J Dermatol; 2004 May; 150(5):958-65. PubMed ID: 15149509
[TBL] [Abstract][Full Text] [Related]
79. Folliculitis decalvans and human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Araújo AQ; Andrada-Serpa MJ; Paulo-Filho TA; Rodrigues MT; Prado LA
Clin Infect Dis; 1995 Mar; 20(3):696-9. PubMed ID: 7756498
[TBL] [Abstract][Full Text] [Related]
80. Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.
Chaves DG; Sales CC; de Cássia Gonçalves P; da Silva-Malta MC; Romanelli LC; Ribas JG; de Freitas Carneiro-Proietti AB; Martins ML
J Med Virol; 2016 Aug; 88(8):1438-47. PubMed ID: 26800845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]